Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.

Wolfgang Eisterer; Gudrun Piringer; Alexander DE Vries; Dietmar Öfner; Richard Greil; Jörg Tschmelitsch; Hellmut Samonigg; Lidija Sölkner; Michael Gnant; Josef Thaler

doi:10.21873/anticanres.11617

Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.

Wolfgang Eisterer
, Gudrun Piringer
, Alexander DE Vries
, Dietmar Öfner
, Richard Greil (Co-author)
, Jörg Tschmelitsch
, Hellmut Samonigg
, Lidija Sölkner
, Michael Gnant
, Josef Thaler

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

13 Citations (Web of Science)

Original language	English
Pages (from-to)	2683-2691
Journal	ANTICANCER RESEARCH
Volume	37
Issue number	5
DOIs	https://doi.org/10.21873/anticanres.11617
Publication status	Published - 2017

Keywords

METASTATIC COLORECTAL-CANCER
TOTAL MESORECTAL EXCISION
PREOPERATIVE RADIOTHERAPY
POSTOPERATIVE CHEMORADIOTHERAPY
ADJUVANT CHEMOTHERAPY
RANDOMIZED-TRIAL
FLUOROURACIL
LEUCOVORIN
SURGERY
SURVIVAL

Access to Document

10.21873/anticanres.11617

Cite this

Eisterer, W., Piringer, G., DE Vries, A., Öfner, D., Greil, R., Tschmelitsch, J., Samonigg, H., Sölkner, L., Gnant, M., & Thaler, J. (2017). Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study. ANTICANCER RESEARCH , 37(5), 2683-2691. https://doi.org/10.21873/anticanres.11617

Eisterer, Wolfgang ; Piringer, Gudrun ; DE Vries, Alexander et al. / Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study. In: ANTICANCER RESEARCH 2017 ; Vol. 37, No. 5. pp. 2683-2691.

@article{ddfd99ef6ac54935a0b360c75f8bf849,

title = "Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.",

keywords = "METASTATIC COLORECTAL-CANCER, TOTAL MESORECTAL EXCISION, PREOPERATIVE RADIOTHERAPY, POSTOPERATIVE CHEMORADIOTHERAPY, ADJUVANT CHEMOTHERAPY, RANDOMIZED-TRIAL, FLUOROURACIL, LEUCOVORIN, SURGERY, SURVIVAL",

author = "Wolfgang Eisterer and Gudrun Piringer and \{DE Vries\}, Alexander and Dietmar {\"O}fner and Richard Greil and J{\"o}rg Tschmelitsch and Hellmut Samonigg and Lidija S{\"o}lkner and Michael Gnant and Josef Thaler",

note = "Greil: Paracelsus Med Univ, Dept Internal Med 3, Salzburg, Austria",

year = "2017",

doi = "10.21873/anticanres.11617",

language = "English",

volume = "37",

pages = "2683--2691",

journal = "ANTICANCER RESEARCH ",

issn = "0250-7005",

number = "5",

}

Eisterer, W, Piringer, G, DE Vries, A, Öfner, D, Greil, R, Tschmelitsch, J, Samonigg, H, Sölkner, L, Gnant, M & Thaler, J 2017, 'Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.', ANTICANCER RESEARCH , vol. 37, no. 5, pp. 2683-2691. https://doi.org/10.21873/anticanres.11617

Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study. / Eisterer, Wolfgang; Piringer, Gudrun; DE Vries, Alexander et al.
In: ANTICANCER RESEARCH , Vol. 37, No. 5, 2017, p. 2683-2691.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.

AU - Eisterer, Wolfgang

AU - Piringer, Gudrun

AU - DE Vries, Alexander

AU - Öfner, Dietmar

AU - Greil, Richard

AU - Tschmelitsch, Jörg

AU - Samonigg, Hellmut

AU - Sölkner, Lidija

AU - Gnant, Michael

AU - Thaler, Josef

N1 - Greil: Paracelsus Med Univ, Dept Internal Med 3, Salzburg, Austria

PY - 2017

Y1 - 2017

KW - METASTATIC COLORECTAL-CANCER

KW - TOTAL MESORECTAL EXCISION

KW - PREOPERATIVE RADIOTHERAPY

KW - POSTOPERATIVE CHEMORADIOTHERAPY

KW - ADJUVANT CHEMOTHERAPY

KW - RANDOMIZED-TRIAL

KW - FLUOROURACIL

KW - LEUCOVORIN

KW - SURGERY

KW - SURVIVAL

U2 - 10.21873/anticanres.11617

DO - 10.21873/anticanres.11617

M3 - Original Article

C2 - 28476845

SN - 0250-7005

VL - 37

SP - 2683

EP - 2691

JO - ANTICANCER RESEARCH

JF - ANTICANCER RESEARCH

IS - 5

ER -

Eisterer W, Piringer G, DE Vries A, Öfner D, Greil R, Tschmelitsch J et al. Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study. ANTICANCER RESEARCH . 2017;37(5):2683-2691. doi: 10.21873/anticanres.11617